
Illumina Ordered To Pay BGI Subsidiary $333 Million In DNA-sequencing Patent Case
By Blake Brittain (Reuters) -A Delaware jury on Friday ordered Illumina Inc to pay more than $333 million to a U.S. unit of Chinese genetic analysis company BGI Genomics after finding that Illumina’s DNA-sequencing systems infringed two patents. The jury also said https://tmsnrt.rs/39K62Cz Illumina infringed the patents willfully, and that three patents it had accused…